Related references
Note: Only part of the references are listed.Immunologic privilege in the central nervous system and the blood-brain barrier
Leslie L. Muldoon et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier
Chaodong Wang et al.
MOLECULAR IMMUNOLOGY (2013)
Regulation of the inflammatory response of vascular endothelial cells by EPAC1
Euan Parnell et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models
Yukio Takeshita et al.
IMMUNOLOGICAL REVIEWS (2012)
Blood-Brain Barrier Alterations in the Cerebral Cortex in Experimental Autoimmune Encephalomyelitis
Mariella Errede et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Preclinical Retinal Neurodegeneration in a Model of Multiple Sclerosis
Richard Fairless et al.
JOURNAL OF NEUROSCIENCE (2012)
Going Against the Tide - How Encephalitogenic T Cells Breach the Blood-Brain Barrier
Ruth Lyck et al.
JOURNAL OF VASCULAR RESEARCH (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 Clinical Trial
A. J. Coles et al.
NEUROLOGY (2012)
Interferon-β Therapy Against EAE Is Effective Only When Development of the Disease Depends on the NLRP3 Inflammasome
Makoto Inoue et al.
SCIENCE SIGNALING (2012)
Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis
Friederike Pfeiffer et al.
ACTA NEUROPATHOLOGICA (2011)
Evolution of the Blood-Brain Barrier in Newly Forming Multiple Sclerosis Lesions
Maria I. Gaitan et al.
ANNALS OF NEUROLOGY (2011)
Tight Junctions in Brain Barriers During Central Nervous System Inflammation
Caroline Coisne et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking
Kerstin Goebel et al.
JOURNAL OF AUTOIMMUNITY (2011)
Pathway inhibition: emerging molecular targets for treating glioblastoma
Wolfgang Wick et al.
NEURO-ONCOLOGY (2011)
Calcium-Dependent Isoforms of Protein Kinase C Mediate Posttetanic Potentiation at the Calyx of Held
Diasynou Fioravante et al.
NEURON (2011)
The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence
Jorge Ivan Alvarez et al.
SCIENCE (2011)
Cellular mechanisms of IL-17-induced blood-brain barrier disruption
Jula Huppert et al.
FASEB JOURNAL (2010)
Blockade of PKC-beta protects HUVEC from advanced glycation end products induced inflammation
Youhua Xu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2010)
Activation of PKC isoform βI at the blood-brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain
Robert R. Rigor et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
Protein kinase C activation modulates reversible increase in cortical blood-brain barrier permeability and tight junction protein expression during hypoxia and posthypoxic reoxygenation
Colin L. Willis et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
Angiotensin II sustains brain inflammation in mice via TGF-β
Tobias V. Lanz et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma
Wolfgang Wick et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE
Jami Bennett et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Role of PKCβII and PKCδ in blood-brain barrier permeability during aglycemic hypoxia
Young-Ae Kim et al.
NEUROSCIENCE LETTERS (2010)
Repetitive Pertussis Toxin Promotes Development of Regulatory T Cells and Prevents Central Nervous System Autoimmune Disease
Martin S. Weber et al.
PLOS ONE (2010)
The role of protein kinase C in the opening of blood-brain barrier induced by electromagnetic pulse
Lian-Bo Qiu et al.
TOXICOLOGY (2010)
Wnt/β-catenin signaling is required for CNS, but not non-CNS, angiogenesis
Richard Daneman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown
Azeb Tadesse Argaw et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A molecular trio in relapse and remission in multiple sclerosis
Lawrence Steinman
NATURE REVIEWS IMMUNOLOGY (2009)
A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma
F. Morschhauser et al.
ANNALS OF ONCOLOGY (2008)
Wnt/β-catenin signaling controls development of the blood-brain barrier
Stefan Liebner et al.
JOURNAL OF CELL BIOLOGY (2008)
Glia-dependent TGF-β signaling, acting independently of the TH17 pathway, is critical for initiation of murine autoimmune encephalomyelitis
Jian Luo et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphoma
Michael J. Robertson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Synergistic antiglioma activity of radiotherapy and enzastaurin
Ghazaleh Tabatabai et al.
ANNALS OF NEUROLOGY (2007)
Phase I dose escalation and pharmacokinetic study of enzastaurin, an oral protein kinase C beta inhibitor, in patients with advanced cancer
Michael A. Carducci et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite
M Platten et al.
SCIENCE (2005)
Murine brain capillary endothelial cells exhibit improved barrier properties under the influence of hydrocortisone
C Weidenfeller et al.
BRAIN RESEARCH (2005)
The protein kinase Cβ-selective inhibitor, enzastaurin (LY317615.HCI), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts
JR Graff et al.
CANCER RESEARCH (2005)
The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms
B Engelhardt et al.
TRENDS IN IMMUNOLOGY (2005)
Protein kinase C βII regulates Akt phosphorylation on Ser-473 in a cell type- and stimulus-specific fashion
Y Kawakami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Protein kinase C (PKC) βII induces cell invasion through a Ras/Mek-, PKCι/Rac1-dependent signaling pathway
J Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosis
SS Zamvil et al.
NEURON (2003)
Permeabilization in a cerebral endothelial barrier model by pertussis toxin involves the PKC effector pathway and is abolished by elevated levels of cAMP
KE Brückener et al.
JOURNAL OF CELL SCIENCE (2003)
Tight junctions of the blood-brain barrier: Development, composition and regulation
H Wolburg et al.
VASCULAR PHARMACOLOGY (2002)
The facilitated component of intestinal glucose absorption
GL Kellett
JOURNAL OF PHYSIOLOGY-LONDON (2001)
Complex phenotype of mice lacking occludin, a component of tight junction strands
M Saitou et al.
MOLECULAR BIOLOGY OF THE CELL (2000)
Correlation of tight junction morphology with the expression of tight junction proteins in blood-brain barrier endothelial cells
S Liebner et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2000)